Despite that, and although there was a relatively small number of patients who died during the follow-up period (24%), we observed a significant negative impact of increased SHH expression on different types of survival in our cohort of BC patients, which has been consistently reported previously [19,21,36,45,47,48]. The gene discussed is SHH; the disease is breast cancer.